US, China and EU make progress on swine flu vaccines
This article was originally published in SRA
Executive Summary
The accelerated approval process adopted by most drug regulatory authorities to allow speedier development of vaccines for the 2009 H1N1 influenza A (swine flu) virus is beginning to yield results. Yesterday, the US Food and Drug Administration announced it had approved four vaccines against the H1N1 virus1.